The AACR is the oldest and largest cancer research society; its April meeting is where early-stage science and first-in-human data appear.
The American Association for Cancer Research, based in Philadelphia, is the oldest and largest cancer research society, and its Annual Meeting each April is where early-stage science and first-in-human data appear. It runs Project GENIE, the shared clinico-genomic registry that OnCo carries as a collection, publishes Cancer Research, Cancer Discovery, Clinical Cancer Research and Cancer Immunology Research, and issues a quarterly digest of FDA approvals, with Margaret Foti, Antoni Ribas and Philip D. Greenberg among the people linked. OnCo connects it to bottlenecks on data silos, irreproducible preclinical results and secrecy, and to ideas such as plenary slots for negative trials and universal sequencing at diagnosis. Whether a society can enforce data sharing its members resist is the fair question. Stand Up To Cancer and the Mark Foundation are linked partners.
Melanoma immunotherapy leader behind pembrolizumab's first trials and the science of why immunotherapy fails.
Has led AACR for more than four decades, growing it into the world's largest cancer research society.
Michael Caligiuri is an NK cell immunologist and past AACR president who leads City of Hope's hospital.
Immunologist who spent four decades engineering T cells to attack leukaemia and solid tumours.
Shares Stand Up To Cancer, Secrecy and intellectual property block collaboration, Funding follows fashion, not burden.
Shares Secrecy and intellectual property block collaboration, Preclinical results do not reproduce, Data silos.
Shares Cancer Research, Cancer Discovery.
Shares The Mark Foundation for Cancer Research, Funding follows fashion, not burden.
Shares Cancer Discovery, Clinical Cancer Research.
Shares The Mark Foundation for Cancer Research, Funding follows fashion, not burden.
Shares AACR Project GENIE, Data silos.
Shares AACR Project GENIE, Funding follows fashion, not burden.